| Symbol |
Name |
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
|
AHI1
|
Abelson helper integration site 1
|
|
APOBEC1
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ATG14
|
autophagy related 14
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATXN1
|
ataxin 1
|
|
ATXN7
|
ataxin 7
|
|
BLVRA
|
biliverdin reductase A
|
|
BMP4
|
bone morphogenetic protein 4
|
|
C5AR1
|
complement component 5a receptor 1
|
|
CA9
|
carbonic anhydrase IX
|
|
CALR
|
calreticulin
|
|
CD34
|
CD34 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDX2
|
caudal type homeobox 2
|
|
CEP290
|
centrosomal protein 290kDa
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CLPP
|
caseinolytic mitochondrial matrix peptidase proteolytic subunit
|
|
CLPX
|
caseinolytic mitochondrial matrix peptidase chaperone subunit
|
|
COMT
|
catechol-O-methyltransferase
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DSG3
|
desmoglein 3
|
|
EDN3
|
endothelin 3
|
|
EGFR
|
epidermal growth factor receptor
|
|
EP400
|
E1A binding protein p400
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ESR1
|
estrogen receptor 1
|
|
EYS
|
eyes shut homolog (Drosophila)
|
|
FABP7
|
fatty acid binding protein 7, brain
|
|
FBN1
|
fibrillin 1
|
|
FBRS
|
fibrosin
|
|
FLG
|
filaggrin
|
|
FTO
|
fat mass and obesity associated
|
|
GAA
|
glucosidase, alpha; acid
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
H2AFX
|
H2A histone family, member X
|
|
HDAC9
|
histone deacetylase 9
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL3
|
interleukin 3
|
|
IL6
|
interleukin 6
|
|
INHBA
|
inhibin, beta A
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JARID2
|
jumonji, AT rich interactive domain 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT18
|
keratin 18, type I
|
|
LCN2
|
lipocalin 2
|
|
LMNA
|
lamin A/C
|
|
LPL
|
lipoprotein lipase
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPT
|
microtubule-associated protein tau
|
|
MED12
|
mediator complex subunit 12
|
|
MIR148A
|
microRNA 148a
|
|
MLC1
|
megalencephalic leukoencephalopathy with subcortical cysts 1
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MUS81
|
MUS81 structure-specific endonuclease subunit
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NES
|
nestin
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NPHP1
|
nephronophthisis 1 (juvenile)
|
|
NR2E3
|
nuclear receptor subfamily 2, group E, member 3
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NUP62
|
nucleoporin 62kDa
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
PBK
|
PDZ binding kinase
|
|
PDPN
|
podoplanin
|
|
PIK3C2B
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTH
|
parathyroid hormone
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RCOR1
|
REST corepressor 1
|
|
RET
|
ret proto-oncogene
|
|
S100A4
|
S100 calcium binding protein A4
|
|
SENP5
|
SUMO1/sentrin specific peptidase 5
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOX6
|
SRY (sex determining region Y)-box 6
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1
|
|
TARDBP
|
TAR DNA binding protein
|
|
TASP1
|
taspase, threonine aspartase, 1
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TH
|
tyrosine hydroxylase
|
|
TLR4
|
toll-like receptor 4
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TP53
|
tumor protein p53
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRAPPC9
|
trafficking protein particle complex 9
|
|
TRB
|
T cell receptor beta locus
|
|
TRG
|
T cell receptor gamma locus
|
|
TRIM44
|
tripartite motif containing 44
|
|
VDAC1
|
voltage-dependent anion channel 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|